91 Results

People

  1. Motzer
    Motzer
  2. Makker
    Makker
  3. Abou-Alfa
    Abou-Alfa
  4. Drilon
    Drilon
  5. Lee
    Lee
  6. Voss
    Voss
  7. Wong
    Wong
  8. Aghajanian
    Aghajanian
  9. Carlo
    Carlo
  10. Konner
    Konner

Groups

  1. Department of Medicine (72)
  2. Solid Tumor Oncology Division (70)
  3. Genitourinary Oncology Service (30)
  4. GDMT, Medicine (18)
  5. Gynecologic Medicine Service (18)
  6. Gynecology Disease Management Team (18)
  7. Radiology, Department of (12)
  8. Gastrointestinal Oncology Service (11)
  9. Center for Pancreatic Cancer Research (9)
  10. Weinberg Fellows (9)
  1. "lenvatinib"
Formats
  1. Journal Article (58)
  2. Review (19)
  3. Editorial (3)
  4. Guidelines (3)
  5. Research Letter (3)
  6. Correspondence (2)
  7. Meeting Abstract (2)
  8. Book Section (1)
Groups
  1. Department of Medicine (72)
  2. Solid Tumor Oncology Division (70)
  3. Genitourinary Oncology Service (30)
  4. GDMT, Medicine (18)
  5. Gynecologic Medicine Service (18)
  6. Gynecology Disease Management Team (18)

More Groups

People
  1. Robert Motzer (25)
  2. Vicky Makker (16)
  3. Ghassan Abou-Alfa (9)
  4. Chung-Han Lee (7)
  5. Alexander Drilon (4)
  6. Martin Voss (4)

More People

Years
  1. 2025 (9)
  2. 2024 (18)
  3. 2023 (18)
  4. 2022 (12)
  5. 2021 (11)
  6. 2020 (9)

More Years

Publications
  1. European Urology (5)
  2. Cancers (4)
  3. The Oncologist (4)
  4. Annals of Oncology (3)
  5. Journal of Clinical Oncology (3)
  6. Journal of Gastrointestinal Oncology (3)

More Publications

Publishers
  1. Elsevier Inc. (16)
  2. Elsevier Science, Inc. (8)
  3. Oxford University Press (8)
  4. MDPI (4)
  5. Nature Publishing Group (4)
  6. Wiley Blackwell (4)

More Publishers

Results (91)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Therapeutic inhibition of ATR in differentiated thyroid cancer
    Journal Article

    Lin, S. F.; Lee, Y. Y.; Wu, M. H.; Lu, Y. L.; Yeh, C. N.; Chen, W. Y.; Chou, T. C.; Wong, R. J.
    Endocrine-Related Cancer (2023)

    Fulltext@MSK | Save
  • Patient-reported outcome measurement and reporting for patients with advanced renal cell carcinoma: A systematic literature review
    Review

    Motzer, R. J.; Rane, P. P.; Saretsky, T. L.; Pawar, D.; Martin Nguyen, A.; Sundaram, M.; Burgents, J.; Pandey, R.; Rudell, K.
    European Urology (2023)

    Fulltext@MSK | Save
  • Tumor lenvatinib addiction and withdrawal rebound response in patients with advanced endometrial cancer
    Journal Article

    Lam, C.; Sarasohn, D.; Weigelt, B.; Zamarin, D.
    Gynecologic Oncology Reports (2023)

    Fulltext@MSK | Save
  • Adverse events and oncologic outcomes with combination lenvatinib and pembrolizumab for the treatment of recurrent endometrial cancer
    Journal Article

    Zammarrelli, W. A. 3rd; Ma, W.; Espino, K.; Gordhandas, S.; Yeoshoua, E.; Ehmann, S.; Zhou, Q.; Iasonos, A.; Abu-Rustum, N. R.; Aghajanian, C.; more...
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • Phase 3 CLEAR study in patients with advanced renal cell carcinoma: Outcomes in subgroups for the lenvatinib-plus-pembrolizumab and sunitinib arms
    Journal Article

    Grünwald, V.; Powles, T.; Eto, M.; Kopyltsov, E.; Rha, S. Y.; Porta, C.; Motzer, R.; Hutson, T. E.; Méndez-Vidal, M. J.; Hong, S. H.; more...
    Frontiers in Oncology (2023)

    Fulltext@MSK | Save
  • Pembrolizumab plus lenvatinib as first-line therapy for advanced non-clear-cell renal cell carcinoma (KEYNOTE-B61): A single-arm, multicentre, phase 2 trial
    Journal Article

    Albiges, L.; Gurney, H.; Atduev, V.; Suarez, C.; Climent, M. A.; Pook, D.; Tomczak, P.; Barthelemy, P.; Lee, J. L.; Stus, V.; more...
    Lancet Oncology (2023)

    Fulltext@MSK | Save
  • Survival by depth of response and efficacy by International Metastatic Renal Cell Carcinoma Database Consortium subgroup with lenvatinib plus pembrolizumab versus sunitinib in advanced renal cell carcinoma: Analysis of the phase 3 randomized CLEAR Study
    Journal Article

    Grünwald, V.; Powles, T.; Kopyltsov, E.; Kozlov, V.; Alonso-Gordoa, T.; Eto, M.; Hutson, T.; Motzer, R.; Winquist, E.; Maroto, P.; more...
    European Urology Oncology (2023)

    Fulltext@MSK | Save
  • Biomarker-directed, pembrolizumab-based combination therapy in non-small cell lung cancer: Phase 2 KEYNOTE-495/KeyImPaCT trial interim results
    Journal Article

    Gutierrez, M.; Lam, W. S.; Hellmann, M. D.; Gubens, M. A.; Aggarwal, C.; Tan, D. S. W.; Felip, E.; Chiu, J. W. Y.; Lee, J. S.; Yang, J. C. H.; more...
    Nature Medicine (2023)

    Fulltext@MSK | Save
  • Fibroblasts in liver cancer: Functions and therapeutic translation
    Review

    Affo, S.; Filliol, A.; Gores, G. J.; Schwabe, R. F.
    The Lancet Gastroenterology & Hepatology (2023)

    Fulltext@MSK | Save
  • Characterization and management of adverse reactions from the clear study in advanced renal cell carcinoma treated with lenvatinib plus pembrolizumab
    Journal Article

    Motzer, R.; George, S.; Merchan, J. R.; Hutson, T. E.; Song, X.; Perini, R. F.; Xie, R.; Bapat, U.; Puente, J.
    The Oncologist (2023)

    Fulltext@MSK | Save